Skip to main content
. 2023 Mar 30;13(4):622. doi: 10.3390/biom13040622

Table 1.

The clinical parameters of control individuals and BC patients included in our study.

Variable Control Individuals (n = 12) Stage I BC Patients (n = 12) Stage IV BC Patients (n = 12) p Value
Age
<65 11 5 11 0.0094
≥65 1 7 1
Primary tumor grade
T1 12
T2 1
T3 4 <0.0001
T4 2
N/A 5
Menopause
Pre-Menopause 1 5 0.3168
Post-Menopause 11 7
Molecular Subtype
Luminal A 4 4
Luminal B 8 8 1.0000
Metastasis
Bone only N/D 7
Bone and other sites N/D 5

N/D—not detected.